Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jean-Christophe_Tellier
|
| gptkbp:focusesOn |
immunology
neurology |
| gptkbp:foundedYear |
1928
|
| gptkbp:founder |
gptkb:Emmanuel_Janssen
|
| gptkbp:headquartersLocation |
gptkb:Brussels,_Belgium
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:netIncome |
€1.1 billion (2023)
|
| gptkbp:notableEmployee |
gptkb:Jean-Christophe_Tellier
|
| gptkbp:numberOfEmployees |
~8700
|
| gptkbp:parentCompany |
gptkb:UCB_S.A.
|
| gptkbp:products |
gptkb:Briviact
gptkb:Cimzia gptkb:Keppra gptkb:Neupro gptkb:Vimpat |
| gptkbp:revenue |
€5.5 billion (2023)
|
| gptkbp:stockExchange |
gptkb:Euronext_Brussels
|
| gptkbp:stockSymbol |
gptkb:UCB
|
| gptkbp:website |
https://www.ucb.com/
|
| gptkbp:bfsParent |
gptkb:Heiko_von_der_Leyen
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCB Biopharma
|